On 20 January 2026, Ropes & Gray’s Global Life Sciences Regulatory & Compliance team hosted the “Life Sciences Regulatory Outlook 2026” webinar.

Life sciences companies must work to sustain healthcare advancement and development while uncertainty around National Institute of Health (NIH) funding and other administrative changes stress the ...

As life sciences companies expand internationally, regulatory readiness must evolve into a strategic capability that supports ...

For more than 15 years, Aldo Vidinha has worked at the intersection of engineering, quality, and regulatory strategy in the life sciences. His career has taken him across Europe, Asia, the United ...

Acquisition will broaden healthcare consulting capabilities and strengthen support for quality, compliance, and ...

In the high stakes world of health care and life sciences organizations, AI poses unique opportunities and challenges. Corporate Counsel and Ropes & Gray recently collaborated on a survey of this ...

Helping organizations deploy artificial intelligence safely, compliantly, and with confidence AI has enormous potential ...

AI is moving fast. Life sciences organizations are adopting it to improve quality oversight, accelerate development and reduce operational overhead. From risk assessments and supplier audits to ...

Many organizations are operating with constrained resources while trying to expand, launch new therapies, or scale manufacturing across regions. At the same time, regulatory expectations and ...

Just 27% of respondents feel very confident in their organization's ability to remain compliant with evolving regulations. Fewer than half of life science organizations have invested in updated ...

Artificial intelligence (AI) continues to upend how businesses operate, and the life sciences field is no exception. Generative AI provides life sciences companies the ability to identify and learn ...